In our effort to find new whitening agents, we evaluated the effects of representative chalcones [4-hydroxyderricin (1), xanthoangelol (2), xanthoangelol H (3), deoxyxanthoangelol H (4), and deoxydihydroxanthoangelol H (5)] contained in the stem of Angelica keiskei on tyrosinase and melanin formation in B16 melanoma cells. In addition, the antioxidant effects of these chalcones in ORAC and DPPH assays were also determined. Interestingly, all chalcones (1-5) inhibit melanin formation in B16 melanoma cells, with low cytotoxicity.
Skin color results from the presence and ratio of several chromophores in the skin. Oxyhaemoglobin (bright red), reduced haemoglobin (bluish red) and bilirubin (yellow) are found in the small blood vessels of the dermis. Pigmentary disorders are numerous and occur as a result of both genetic and environmental factors [1] .
Melanin synthesis starts with the hydroxylation of L-tyrosine to Ldihydroxyphenylalanine (DOPA), which is followed by the oxidation of L-DOPA to L-DOPA quinone [2] . DOPA oxidation produces a highly reactive intermediate that is further oxidized to form melanin by a free radical-coupling pathway. If free radicals are inappropriately processed in melanin synthesis, hydrogen peroxide (H 2 O 2 ) is generated, leading to the production of hydroxyl radicals (HO•) and other reactive oxygen species (ROS) [3] .
An intensive search for a naturally occurring substance that would inhibit melanin pigmentation has been performed. Up to now, most research on the regulation of melanogenesis has focused on the factors affecting tyrosinase. Kojic acid and arbutin are known as tyrosinase inhibitors and are used as skin-whitening cosmetics [4] . Also, hydroquinone-related compounds have been used as effective depigmentation agents for skin pigmentation, but they are strong irritants and exhibit cell toxicity [5] .
Angelica keiskei (family Umbelliferae) is a large perennial plant, grown originally in Japan. It is a dark green leafy vegetable that has been recognized as a medicinally important herb that is cultivated throughout Asia. Putative beneficial effects of A. keiskei reported in animal models include suppression of gastric acid secretion, antitumourigenesis, anti-thrombosis, antihypertension, suppression of histamine secretion, vasodilation, antioxidant [6] and induced apoptosis of stomach cancer cells [7] .
In our continuing search for melanin biosynthesis inhibitors, we found that the ethanol extract of the stem of A. keisei showed melanin inhibition with low cytotoxicity. In this paper, we have examined the effects of representative chalcones from A. keiskei on melanin formation in B16 melanoma cells and on tyrosinase, and their antioxidant activities by ORAC and DPPH assays.
Chalcones are a group of compounds widely present in higher plants, which may have various biological activities. They contain two aromatic rings with an unsaturated chain and many biological activities have been attributed to this group, such as anticancer, antiinflammatory, antipyretic, analgesic, cytotoxic, antibacterial, antiinsecticidal, antifungal, antioxidant and phytoestrogenic [8] .
In the present study, we evaluated the effect of the EtOH extract of A. keiskei and some representative chalcones that have been isolated from A. keiskei on melanogenesis in B16 melanoma cells. The EtOH extracts showed melanin inhibition of 48% and cell viability for 91% in B16 melanoma cells at a concentration of 200 µg/mL. The hydrophobic extract of the stem of A. keiskei is known to contain several chalcones, such as compounds 1-5 [9] [10] [11] [12] . Therefore, these were evaluated for their effect on melanin formation in B16 melanoma cells. The IC 50 value of compound 5 was < 15 µM, of 1 and 2 15-20 µM, and of 3 and 4 20-30 µM. These compounds showed more potent inhibitory activity of melanin production in B16 melanoma cells than the positive control, arbutin (IC 50 , 111 µM). Compounds 1 and 2 are isoprenoidsubstituted chalcones and are the major components of A. keiskei [12] , whereas 3, 4 and 5 are minor components [9] . It was reported that the stem of A. keiskei contains chalcones such as 1 (9.39%), 2 (10.3%), 3 (0.0049%) [10] , 4 (0.0007%) and 5 (0.0001%) [9] . The detailed structures of these compounds can be seen in Figure 1 . Cell viability (%) at the IC 50 concentration for melanin production in B16 melanoma cells Compounds 1 and 2 showed similar inhibitory activity of melanin production in B16 melanoma cells with IC 50 values of around 17 µM, and the same tendency was exhibited by compounds 3 and 4 with IC 50 values of around 21 µM. Compound 5 was more potent (IC 50 of 11.6 µM) in inhibiting melanin production than the other compounds. These results showed a similar tendency to those of our previous report [13] in that the isoprenoid-substituted moiety enhanced the ability of flavonoids to inhibit melanin biosynthesis in B16 melanoma cells with less cytotoxicity.
Compounds 3, 4 and 5 also have a cyclic pattern of the isoprenoid moiety, but compound 5 is hydrogenated, being specifically a dihydrochalcone. The inhibition of melanin production of compounds 3 and 4 was similar, with IC 50 values of 21.4 and 20.9 µM, respectively. These inhibition activities were two times lower than that of compound 5 (IC 50 = 11.6µM), which is a hydrogenated compound. Hydrogenation of compound 4 increased its capability to inhibit melanin production in B16 melanoma cells. This finding was supported by our previous report that hydrogenation of chlorophorin to hexahydrochlorophorin enhanced its ability to inhibit melanin production in B16 melanoma cells [14] . In this experiment, we used arbutin as a positive control. Arbutin was reported to be not only effective in reducing melanin production in B16 melanoma cells, but also effective in suppressing melanosomal tyrosinase activity in human melanocyte cell cultures [15] .
Next, we evaluated the effect of 1-5 on mushroom tyrosinase. By using L-tyrosine as a substrate, we found that only compound 2 reduced the tyrosinase activity moderately, by about 45% at a concentration of 74.0 µM ( Table 2 ). The tyrosinase inhibition of compound 2 may relate to its melanin inhibition of B16 melanoma cells, at least in part.
Our findings indicate that the depigmentation mechanism of isoprenoid-and isoprenoid like-substituted chalcones (1-5) involves the suppression of some pigmenting signals that function to stimulate melanogenesis, rather than the inhibition of tyrosinase activity. In order to inhibit tyrosinase activity, an inhibitor would have to penetrate both the melanocyte and the melanosomal membranes, since tyrosinase acts within organelles in melanocytes, so compounds 1, 3, 4, and 5, which did not reduce tyrosinase activity, may be more effective as skin whitening agents than tyrosinase inhibitors. Several melanin biosynthesis inhibitors without the ability to inhibit tyrosinase have been reported [16, 17] . Furthermore, these findings support our previous results in which the compounds with an isoprenoid-substituent, albanin A, artocarpin, brosimone I, cudraflavone B, cudraflavone C, kuwanon C, 6-prenyl apigenin, and norartocarpin showed melanin inhibitory effects in B16 melanoma cells [13] . In the present study, we have found a new biological activity of chalcones in A. keiskei, melanin biosynthesis inhibition in B16 melanoma cells, with less cytotoxicity. The mechanism of these chalcones by which they inhibit melanin production in B16 melanoma cells is still unclear. Further investigation of the molecular basis of inhibition is needed. [8] . It has been generally believed that agents having antioxidant activity show anti-aging, whitening, and anti-inflammatory activities [18] . Since compounds 1-5 have showed promising results as whitening agents, we conducted an antioxidant assay (ORAC) in order to determine their ability to counteract oxidative stress from UV radiation. Table 3 presents the ORAC and DPPH results for compounds 1-5. In the present study, their ORAC property was grouped as follow : < 1μM TE/μM for compound 4, and 1-5 µM for 1, 2, 3, and 5. Compound 3 was found to be the strongest antioxidant, while 4 was the weakest. In the DPPH assay, none of the compounds showed activity.
In conclusion, all the investigated chalcones showed melanin biosynthesis inhibitory activities in B16 melanoma cells, with less cytotoxicity. These inhibitory activities are probably not caused by their tyrosinase inhibitory activity, which is low. These compounds showed moderate antioxidant activities in the ORAC assay. The accumulation of these properties on the basis of their chemical structure led us to the design of depigmenting agents. However, safety is a primary consideration for practical use in humans.
